Corticosteroids are in widespread clinical use but are known to have adverse skeletal side effects. Moreover, it is not known how soon these effects become apparent. Here, we describe a longitudinal approach to evaluate the short-term implications of excess corticosteroid exposure by quantitative in vivo magnetic resonance imaging and spectroscopy in conjunction with digital image processing and analysis in a rabbit model. Two-week treatment with dexamethasone induced a significant reduction in trabecular bone volume, which occurred at the expense of uniform trabecular thinning without affecting network architecture. Paralleling the loss in bone volume was conversion of hematopoietic to yellow marrow in the femoral metaphysis and atrophy of the femoral epiphyseal growth plate. This work demonstrates that detailed quantitative morphometric and physiological information can be obtained noninvasively at multiple skeletal locations. The method is likely to eventually replace invasive histomorphometry in that it obviates the need to sacrifice groups of animals at multiple time points. Finally, this work, which was performed on a clinical scanner, has implications for evaluating patients on high-dose steroid treatment.B one loss and concomitant fractures of the vertebrae and hip are common clinical consequences of corticosteroid (CS) treatment for inflammatory conditions (1). The overall incidence of osteopenia induced by treatment with CS for a period of less than 6 months is approximately 50% (2). Further, excess CS causes conversion of hematopoietic to fatty bone marrow (3). Besides bone loss, CS treatment is known to have multiple other skeletal implications and thus represents a major public health problem. Of particular concern are pediatric patients treated with high doses of CS (4, 5). Little, however, is known about the early response to supraphysiologic CS levels on the musculoskeletal system.Clinically, fracture risk is most commonly assessed on the basis of bone mineral density (BMD) measured with dual-energy x-ray bone absorptiometry (DEXA) or peripheral quantitative computed tomography (p-QCT). However, it is well known that BMD is not the sole determinant of bone strength and that architecture plays a significant role in conferring strength to the trabecular network (6-8). Unlike bone mineral densitometry, which affords a measure of global or regional bone density, we and others have shown that magnetic resonance microimaging ( -MRI) can quantify trabecular bone microarchitecture in vitro in specimens and biopsies (9-13) and in vivo in laboratory animals and humans (14-16). Whereas microcomputed tomography ( -CT) can generate high-resolution images of trabecular bone architecture (17), magnetic resonance (MR) is unique in that it is also able to provide detailed information on structure and function of soft tissues and bone marrow, which are also affected by steroid treatment.One of the difficulties of imaging microarchitecture in vivo is achievement of sufficient resolution and signal-to-noise ratio to...